Stock Analiz

Hims & Hers Health, Inc. (HIMS) stock forecast and price target

Price $19.73 · data as of November 13, 2026

12-month price target

Average target$28.31
Upside / downside+43.5%
Analysts13
ConsensusHold
Low $23.00Average $28.31High $40.00

Gold marker: average target · white marker: today’s price ($19.73)

Analyst ratings

Strong buy 2Buy 1Hold 12Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.91−95.5%$3.1B
Next fiscal year
ends December 31, 2027
$-0.07+708.0%$3.9B
Quarter after
ends December 31, 2026
$-0.03+15.8%$904M

Consensus of the analysts covering Hims & Hers Health, updated daily. In the last 30 days 0 estimates were raised and 2 lowered.

Our model vs. Wall Street

Analysts see 43.5% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Hims & Hers Health’s intrinsic value about 20% below today’s market value, and it scores 1.8 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Hims & Hers Health stock price target?

The average 12-month target from 13 analysts is $28.31, 43.5% above the current price of $19.73 Targets range from $23.00 to $40.00.

Is Hims & Hers Health a buy according to analysts?

The consensus rating is “Hold” (2 strong buy, 1 buy, 12 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Hims & Hers Health expected to earn?

Analysts expect EPS of $-0.91 for the fiscal year ending December 31, 2026 and $-0.07 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.